These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25907917)

  • 1. Recurrent Stroke while on Antiplatelet Therapy.
    John S; Katzan I
    Neurol Clin; 2015 May; 33(2):475-89. PubMed ID: 25907917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Front-loading with clopidogrel plus aspirin followed by dual antiplatelet therapy in the prevention of early stroke recurrence.
    Censori B
    Expert Rev Neurother; 2014 Jul; 14(7):723-34. PubMed ID: 24881887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of antiplatelet therapy in cardiovascular disease II: Ischemic stroke.
    Cavendish JJ; Cramer SC; Graham GD
    Curr Med Res Opin; 2004 Nov; 20(11):1845-9. PubMed ID: 15537485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights in antiplatelet therapy for patients with ischemic stroke.
    Chaturvedi S; Bhattacharya P
    Neurologist; 2011 Sep; 17(5):255-62. PubMed ID: 21881467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of antiplatelet study medication and risk of recurrent stroke and cardiovascular events: results from the PRoFESS study.
    Weimar C; Cotton D; Sha N; Sacco RL; Bath PM; Weber R; Diener HC
    Cerebrovasc Dis; 2013; 35(6):538-43. PubMed ID: 23816610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review.
    Simmons BB; Yeo A; Fung K; ;
    Postgrad Med; 2010 Mar; 122(2):49-53. PubMed ID: 20203455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of B-vitamin therapy by antiplatelet use on risk of recurrent vascular events after stroke.
    Arshi B; Ovbiagele B; Markovic D; Saposnik G; Towfighi A
    Stroke; 2015 Mar; 46(3):870-3. PubMed ID: 25649801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on selecting and adjusting antiplatelet therapy for prevention of noncardiogenic, recurrent ischemic stroke.
    Lutsep H
    Expert Rev Cardiovasc Ther; 2011 Oct; 9(10):1295-303. PubMed ID: 21985542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual antiplatelet therapy in acute ischemic stroke.
    Asdaghi N; Romano JG
    Curr Atheroscler Rep; 2015 Jul; 17(7):37. PubMed ID: 25990661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
    Diener HC; Sacco R; Yusuf S; ;
    Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic stroke in patients receiving aspirin.
    Pujol Lereis VA; Ameriso S; Povedano GP; Ameriso SF
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):868-72. PubMed ID: 21703876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent Ischemic Strokes: "Discontinuation of Antiplatelet Drugs Appears to be an Important Preventable Cause".
    Mathew T; John SK; Souza DD; Nadig R; Badachi S; K Sarma GR
    Neurol India; 2021; 69(6):1743-1746. PubMed ID: 34979679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroke and atherothrombosis: an update on the role of antiplatelet therapy.
    Alexandrov AV; Alagona P
    Int J Stroke; 2008 Aug; 3(3):175-81. PubMed ID: 18705896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of antiplatelet in stroke patients with end-stage renal disease undergoing dialysis.
    Chen CY; Lee KT; Lee CT; Lai WT; Huang YB
    Int J Stroke; 2014 Jul; 9(5):580-90. PubMed ID: 24597578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ
    Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet therapy in stroke prevention.
    Apostolakis S; Marín F; Lip GY
    Adv Cardiol; 2012; 47():141-54. PubMed ID: 22906909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
    Reaume KT; Regal RE; Dorsch MP
    Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enteric-coated aspirin versus other antiplatelet drugs in acute non-cardioembolic ischemic stroke: post-marketing study in Japan.
    Takahashi S; Mizuno O; Sakaguchi T; Yamada T; Inuyama L
    Adv Ther; 2014 Jan; 31(1):118-29. PubMed ID: 24385407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC
    Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.